Skip to content

Study to test the effectiveness of GroZen Haircare Liquid on Hair Growth and Protection in Adults.

A clinical study to evaluate the efficacy of GroZen haircare liquid in promoting hair growth & protection in adult subjects over 24 weeks - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080812
Enrollment
30
Registered
2025-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: GroZen haircare liquid: The test product will be instructed to use for period of 24 weeks. Apply sufficient amount of product evenly to one half of the scalp and follow the same on the

Sponsors

Stempeutics Research Pvt. Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects experiencing hair damage. 2.Subjects complaining of hair thinning and hair fall. 3.Subjects willing to give a written informed consent and willing to abide by and comply with the study protocol.

Exclusion criteria

Exclusion criteria: 1.Subjects who have undergone any kind of hair growth treatment in the last 1 months (self-declared). 2.Subjects who have undergone hair transplant. 3.A known history or present condition of allergic response/hypersensitivity to any topical or oral cosmetic, pharmaceutical or nutraceutical product. 4. Subjects on oral medications like topical or systemic corticosteroids, undergoing any chemical hair salon treatment-straightening / perming / colour/ henna for past 2 to 3 months which will compromise the study. 5.Subjects with any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness(self-declared).

Design outcomes

Primary

MeasureTime frame
To evaluate the effectiveness of the test product in promoting hair growth and preventing hair thinning in comparison to baseline determined by dermatological and instrumental assessment.Timepoint: Day-16, Day-14, Day 0, Day 2, Day 56, Day 58, Day 112, Day 114, Day 168, Day 170

Secondary

MeasureTime frame
To evaluate the overall safety of the test productsTimepoint: Day 0, Day 2, Day 56, Day 58, Day 112, Day 114, Day 168, Day 170

Countries

India

Contacts

Public ContactSudhanthiran S

MS Clinical Research Pvt. Ltd

ritambhara@msclinical.com08040917253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026